期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性缺血性脑血管病与血浆脂蛋白相关磷脂酶A2含量的关系 被引量：4

原文传递
导出
摘要 目的探讨急性缺血性脑血管病患者血浆脂蛋白相关磷脂酶A2(Lp-PLA2)与急性缺血性脑血管病的关系。方法急性缺血性脑血管病患者126例,其中短暂性脑缺血发作(TIA)患者35例,急性脑梗死患者91例,分为轻、中、重度脑梗死组。应用ELISA法测定标本中Lp-PLA2水平。结果 Lp-PLA2含量在脑梗死组(47.697±23.865)μg/L明显高于TIA组(31.973±22.078)μg/L(P<0.01);且轻、中度脑梗死组与重度脑梗死组比较差异有统计学意义(P<0.05)。结论血浆Lp-PLA2随缺血性脑血管病严重程度的增加逐渐升高,可能是判断病情严重程度的指标之一。
作者 祁瑞刚 刘海花 钱迅 周健 谢兵 郑兴娟
机构地区 高邮市人民医院神经内科
出处 《江苏医药》 CAS CSCD 北大核心 2012年第14期1710-1712,共3页 Jiangsu Medical Journal
关键词 脂蛋白相关磷脂酶A2 急性缺血性脑血管病
分类号 R741 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献7

二级参考文献19

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量：33020
  • 2Stafforini DM, Tjoelker LW, McCormick SP, et al. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem, 1999, 274:7018-7024.
  • 3Zalewski A, Macphee CH. Role of lipoprotein-associated phospholipase A2 in atherosclerosis : biology, epidemiology, and possible therapeutic. Arterioscler Thromb Vase Biol, 2005, 25 : 923 -931.
  • 4Macphee CH, Nelson J, Zalewski A. Role of lipoproteinassociated phospholipase A2. in atherosclerosis and its potential as a therapeutic target. Currt Opin Pharmacol,2006, 6 : 154-161.
  • 5O' Donoghue M, Morrow DA, Sabatine MS, et al. Lipoproteinassociated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 ( PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation, 2006, 113: 1745-1752.
  • 6Tsimihodimos V, Karabina SA, Tambaki AP, et al. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type Ⅱ A and type Ⅱ B. Arterioscler Thromb Vasc Biol, 2002, 22: 306-311.
  • 7Lavi S, Herrman J, Lavi R, et al. Role of lipoprotein-associated phospholipase A2 in atherosclerosis. Curr Atheroscler Rep, 2008, 10(3) : 230-235.
  • 8Oei HH, van der Meer IM, Hofman A, et al. Lipoprotein-associat- ed phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circula- tion,2005,111(5) :570-575.
  • 9Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associ- ated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atheroselerosis Risk in Communities (ARIC) study. Arch Intern Med, 2005,165 (21 ) : 2479-2484.
  • 10Persson M, Berglund G, Nelson JJ, et al. Lp-PLA2 activity and mass are associated with incre ased incidence of ischemic stroke: a population-based cohort study from Malm6, Sweden. Atheroscle- rosis,2008,200(1) : 191-198.

共引文献33204

同被引文献37

  • 1Hok-Hay S. Oei,Irene M. van der Meer,Albert Hofman,Peter J. Koudstaal,Theo Stijnen,Monique M.B. Breteler,Jacqueline C.M. Witteman.Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study[J]. Circulation . 2005 (5)
  • 2Loukianos S. Rallidis,Constantinos C. Tellis,John Lekakis,Ioannis Rizos,Christos Varounis,Athanasios Charalampopoulos,Maria Zolindaki,Nikolaos Dagres,Maria Anastasiou-Nana,Alexandros D. Tselepis.Lipoprotein-Associated Phospholipase A 2 Bound on High-Density Lipoprotein Is Associated With Lower Risk for Cardiac Death in Stable Coronary Artery Disease Patients[J]. Journal of the American College of Cardiology . 2012 (20)
  • 3Koenig Wolfgang,Twardella Dorothee,Brenner Hermann,Rothenbacher Dietrich.Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arteriosclerosis . 2006
  • 4Jones Gregory T,Deng Meiying,Hammond-Tooke Graeme D,McCormick Sally P A,van Rij Andre M.Increased plasma lipoprotein(a) found in large-artery atherosclerotic, but not small-artery occlusive, stroke. Clinical Chemistry . 2009
  • 5Ait-Oufella H,Mallat Z,Tedgui A.Lp-PLA2 and s PLA2:cardiovascular biomarkers. Med Sci (Paris) . 2014
  • 6Petersen NH,Schmied AB,Zeller JA,etal.LP(a) lLipoprotein and Plasminogen Activity in patients with different Etiology of Ischemic Stroke. Cerebrovascular Diseases . 2007
  • 7Oana Vittos,Bogdan Toana,Alexandros Vittos,Elena Moldoveanu.??Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker(J)Biomarkers . 2012 (4)
  • 8Marie-Germaine Bousser,Isabelle Crassard.??Cerebral venous thrombosis, pregnancy and oral contraceptives(J)Thrombosis Research . 2012
  • 9Anping Cai,Dongdan Zheng,Ruofeng Qiu,Weiyi Mai,Yingling Zhou.??Lipoprotein-associated phospholipase A2（Lp-PLA 2 ）: A novel and promising biomarker forcardiovascular risks assessment(J)Disease Markers . 2013 (5)
  • 10Andrea Artoni,Paolo Bucciarelli,Ida Martinelli.??Cerebral Thrombosis and Myeloproliferative Neoplasms(J)Current Neurology and Neuroscience Reports . 2014 (11)

引证文献4

二级引证文献16

江苏医药
2012年 第14期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部